Tag:Biotechnology Law

Professor Lietzan Named Best Lawyer in FDA Law and Biotechnology Law

August 23rd, 2017

Professor Lietzan has again been named a “Best Lawyer in America” in both FDA Law and Biotechnology Law. This marks the fifth year in a row for FDA Law and…

Latest Edition of The Best Lawyers in America Includes Professor Lietzan

September 16th, 2016

The Best Lawyers in America recently announced that Professor Erika Lietzan was selected to be included in its 23rd edition for her work in biotechnology law and FDA law. Professor…

Professor Lietzan Appointed to Committee Chair Positions in ABA Section of Science and Technology

September 14th, 2016

Professor Erika Lietzan was recently appointed as chair of the Biotechnology Law Committee of the American Bar Association’s Section of Science and Technology. She has held this position in previous…

Professor Lietzan Publishes on Regulation of Biosimilars and Biotechnology Drugs, Devices

May 27th, 2015

Professor Erika Lietzan is the editor of a recently-published book on premarket and postmarket regulation of biotechnology drugs and devices. The book, Medical Biotechnology: Premarket and Postmarket Regulation, contains a…

Colleagues Select Prof. Lietzan for Best Lawyers in America

August 22nd, 2014

Prof. Erika Lietzan was recently selected by her peers for inclusion in The Best Lawyers in America© 2015, in the fields of Food and Drug Administration (FDA) Law and Biotechnology…